Treatment selection for stable ischemic heart disease patients remains a work in progress.
The stable ischemic heart disease guidelines published in 2012 (1) address 2 pathways to …

Medical treatment is the initial treatmentstrategy and is the cornerstone of management in
patients with stable ischemicheart disease (IHD). Many patients are not suitable for …

Stable angina pectoris is the most common clinical manifestation of chronic ischemic heart
disease, the prognosis of which depends on many factors. The authors have analyzed the …

The Japanese Circulation Society (JCS) published the “Guidelines for elective percutaneous
coronary intervention [PCI] in patients with stable coronary disease” in 2000. In 2006 …

Revascularization in Stable Coronary Artery Disease | Cardiology | JAMA | JAMA Network [Skip
to Navigation] Our website uses cookies to enhance your experience. By continuing to use our …

Myocardial revascularisation has been an established mainstay therapy for coronary artery
disease (CAD) since the late 1960s. Rene Favoloro introduced CABG into clinical practice in …

Coronary revascularization can provide important benefits to patients with coronary artery
disease, such as reduced risk for death and reinfarction in patients presenting with acute …

The keynote COURAGE and BARI-2D trials changed the way the interventional community
selects patients for revascularization. What we now consider appropriate, especially for …

Objective To investigate whether revascularisation improves prognosis compared with
medical treatment among patients with stable coronary artery disease. Design Bayesian …

Over the past two decades, clinical and pathologic studies have examined the
pathophysiology of the so-called acute coronary syndromes: unstable angina and non–Q …